NabarPharma OÜ

Active Registry code 16704772 OÜ Tallinn Registered 28 Mar 2023
Compare

NabarPharma OÜ is a OÜ based in Tallinn, registry code 16704772, status: active. Main activity: Translation and interpretation activities. Its annual report for 2025 shows revenue of €10 581 and 0 employees.

Revenue
10 581 €
↓ 59.4% vs 2024
Employees
0
±0 vs 2024

2025 · annual report, e-Äriregister

Position in the industry Other professional, scientific and technical activities · EMTAK 74

  • Revenue · 2025 10 581 €
    industry median 6 586 € · companies in the industry: 7 527
  • Net profit margin · 2025 28.1 %
    industry median 10.4 % · companies in the industry: 5 370

Taxes and turnover

No tax data available. EMTA publishes data for those who paid state taxes, filed a VAT return or had employees in the quarter. New and small companies may be missing.

Financials by year

2023 – 2025
Revenue, € 2025: 10 581 € · −59.4% vs 2024 · industry median 6 586 € · above 58% of the industry
010 00020 00030 0002023 Company: 9 257 € Industry median: 6 395 €20232024 Company: 26 059 € Industry median: 6 500 €20242025 Company: 10 581 € Industry median: 6 586 €2025010 00020 00030 0002023 Company: 9 257 € Industry median: 6 395 €20232024 Company: 26 059 € Industry median: 6 500 €2025 Company: 10 581 € Industry median: 6 586 €2025
  • Company
  • Industry median

Industry: Other professional, scientific and technical activities (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Net profit, € 2025: 2 968 € · −80.9% vs 2024 · industry median 107 € · above 72% of the industry
05 00010 00015 00020 0002023 Company: 5 794 € Industry median: 219 €20232024 Company: 15 543 € Industry median: 183 €20242025 Company: 2 968 € Industry median: 107 €202505 00010 00015 00020 0002023 Company: 5 794 € Industry median: 219 €20232024 Company: 15 543 € Industry median: 183 €2025 Company: 2 968 € Industry median: 107 €2025
  • Company
  • Industry median

Industry: Other professional, scientific and technical activities (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Net profit margin, % 2025: 28.1 % · −31.6 pp vs the year before · industry median 10.4 % · above 67% of the industry
0204060802023 Company: 62.6 % Industry median: 13.2 %20232024 Company: 59.6 % Industry median: 11.3 %20242025 Company: 28.1 % Industry median: 10.4 %20250204060802023 Company: 62.6 % Industry median: 13.2 %20232024 Company: 59.6 % Industry median: 11.3 %2025 Company: 28.1 % Industry median: 10.4 %2025
  • Company
  • Industry median

Industry: Other professional, scientific and technical activities (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Assets, € 2025: 39 653 € · +8.4% vs 2024
010 00020 00030 00040 0002023 Company: 16 065 €20232024 Company: 36 584 €20242025 Company: 39 653 €2025010 00020 00030 00040 0002023 Company: 16 065 €20232024 Company: 36 584 €2025 Company: 39 653 €2025
Equity, € 2025: 24 305 € · +13.9% vs 2024
05 00010 00015 00020 00025 0002023 Company: 5 795 €20232024 Company: 21 337 €20242025 Company: 24 305 €202505 00010 00015 00020 00025 0002023 Company: 5 795 €20232024 Company: 21 337 €2025 Company: 24 305 €2025
Employees 2025: 0 · industry median 1 · above 2% of the industry
0.00.20.40.60.81.02023 Company: 0 Industry median: 120232024 Company: 0 Industry median: 120242025 Company: 0 Industry median: 120250.00.20.40.60.81.02023 Company: 0 Industry median: 120232024 Company: 0 Industry median: 12025 Company: 0 Industry median: 12025
  • Company
  • Industry median

Industry: Other professional, scientific and technical activities (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Financials by year
Year Revenue, € Net profit, € Labour costs, € Assets, € Equity, € Employees
2025 10 581 2 968 0 39 653 24 305 0
2024 26 059 15 543 0 36 584 21 337 0
2023 9 257 5 794 0 16 065 5 795 0

Figures from the company’s own (non-consolidated) balance sheet and income statement. A loss is shown with a minus sign.

Financial ratios for 2025

Net profit margin
28.1 %
Net profit / revenue
Return on equity (ROE)
12.2 %
Net profit / equity
Return on assets (ROA)
7.5 %
Net profit / assets
Equity ratio
61.3 %
Equity / assets
Debt ratio
38.7 %
Liabilities / assets
Current ratio
2.58
Current assets / current liabilities

Annual reports

PDFs from e-Äriregister
Annual reports
Year Period Filed Report Documents
2025 1 Jan 2025 – 31 Dec 2025 22 Jun 2026 Company’s own e-Äriregister
2024 1 Jan 2024 – 31 Dec 2024 12 Jun 2025 Company’s own e-Äriregister
2023 28 Mar 2023 – 31 Dec 2023 29 Feb 2024 Company’s own e-Äriregister

Board

Right of representation

Any member of the management board may represent the private limited company in all transactions.

Owners

Beneficial owners

Founders and other persons

Activities (EMTAK)

  • 74301Translation and interpretation activities Main

Rulings 2

All rulings (PDF)
Rulings
Number, date Title Deadline State Document
Ä 50224935 / 2
2 Sep 2023
 Amendment entry In force
2 Sep 2023
 PDF
Ä 50224935
28 Mar 2023
 First entry In force
28 Mar 2023
 PDF

Sources: e-Äriregister and EMTA. Data updated 31 Oct 2026. Open at the source ↗ · Report an error in the data